Hatletvedt N, Engebrethsen C, Geisler J, Geisler S, Aas T, Lonning P
BMC Cancer. 2025; 25(1):308.
PMID: 39979836
PMC: 11843751.
DOI: 10.1186/s12885-025-13675-2.
Naidoo P, Maharaj A, Ghazi T, Chuturgoon A
Genet Mol Biol. 2025; 48(1):e20230325.
PMID: 39792433
PMC: 11721215.
DOI: 10.1590/1678-4685-GMB-2023-0325.
Levine A, Carpten J, Murphy M, Hainaut P
Cell Death Differ. 2023; 31(1):1-8.
PMID: 38001255
PMC: 10781774.
DOI: 10.1038/s41418-023-01236-8.
Moe S, Erland F, Fromreide S, Lybak S, Brydoy M, Dongre H
Biomedicines. 2023; 11(7).
PMID: 37509476
PMC: 10376802.
DOI: 10.3390/biomedicines11071838.
Fischer N, Ma Y, Gariepy J
J Natl Cancer Inst. 2023; 115(10):1145-1156.
PMID: 37352403
PMC: 10560603.
DOI: 10.1093/jnci/djad106.
Neither the African-Centric S47 Nor P72 Variant of TP53 Is Associated With Reduced Risk of Febrile Malaria in a Malian Cohort Study.
Bhardwaj J, Upadhye A, Gaskin E, Doumbo S, Kayentao K, Ongoiba A
J Infect Dis. 2023; 228(2):202-211.
PMID: 36961831
PMC: 10345479.
DOI: 10.1093/infdis/jiad066.
Relationship Between Genetic Polymorphisms in Cell Cycle Regulatory Gene TP53 and Polycystic Ovarian Syndrome: A Case-Control Study and In Silico Analyses.
Biglari-Zadeh G, Sargazi S, Mohammadi M, Ghasemi M, Majidpour M, Saravani R
Biochem Genet. 2023; 61(5):1827-1849.
PMID: 36856940
DOI: 10.1007/s10528-023-10349-1.
The Role of in Adaptation and Evolution.
Voskarides K, Giannopoulou N
Cells. 2023; 12(3).
PMID: 36766853
PMC: 9914165.
DOI: 10.3390/cells12030512.
TP53 Codon 72 Polymorphism and the Risk of Colorectal Cancer in an Azerbaijani Population.
Yagublu V, Bayramov B, Yuce M, Aslanov H
Turk J Gastroenterol. 2022; 33(6):485-490.
PMID: 35786616
PMC: 9321240.
DOI: 10.5152/tjg.2022.21189.
Association of TP53 gene polymorphisms with the risk of acute lymphoblastic leukemia in Moroccan children.
Skhoun H, Khattab M, Belkhayat A, Chebihi Z, Bakri Y, Dakka N
Mol Biol Rep. 2022; 49(9):8291-8300.
PMID: 35705773
DOI: 10.1007/s11033-022-07643-3.
The genotypes and phenotypes of missense mutations in the proline domain of the p53 protein.
Hoyos D, Greenbaum B, Levine A
Cell Death Differ. 2022; 29(5):938-945.
PMID: 35383292
PMC: 9090814.
DOI: 10.1038/s41418-022-00980-7.
SARS-CoV-2: Understanding the Transcriptional Regulation of ACE2 and TMPRSS2 and the Role of Single Nucleotide Polymorphism (SNP) at Codon 72 of p53 in the Innate Immune Response against Virus Infection.
Lodhi N, Singh R, Rajput S, Saquib Q
Int J Mol Sci. 2021; 22(16).
PMID: 34445373
PMC: 8395432.
DOI: 10.3390/ijms22168660.
Risk of Colorectal Carcinoma May Predispose to the Genetic Variants of the , and Genes Among Nonsmokers in the Saudi Community.
Sindi I, Babalghith A, Tayeb M, Mufti A, Naffadi H, Ekram S
Int J Gen Med. 2021; 14:1311-1323.
PMID: 33883929
PMC: 8055278.
DOI: 10.2147/IJGM.S294802.
Effect of the p53 P72R Polymorphism on Mutant TP53 Allele Selection in Human Cancer.
De Souza C, Madden J, Koestler D, Minn D, Montoya D, Minn K
J Natl Cancer Inst. 2021; 113(9):1246-1257.
PMID: 33555293
PMC: 8633460.
DOI: 10.1093/jnci/djab019.
Identification and functional characterization of new missense SNPs in the coding region of the TP53 gene.
Doffe F, Carbonnier V, Tissier M, Leroy B, Martins I, Mattsson J
Cell Death Differ. 2020; 28(5):1477-1492.
PMID: 33257846
PMC: 8166836.
DOI: 10.1038/s41418-020-00672-0.
Two Functional Genetic Variants and Predisposition to Keloid Scarring in Caucasians.
Dmytrzak A, Boron A, Loniewska B, Lewandowska K, Goracy I, Kaczmarczyk M
Dermatol Res Pract. 2019; 2019:6179063.
PMID: 31827503
PMC: 6881576.
DOI: 10.1155/2019/6179063.
The complementary effect of rs1042522 in and rs1805007 in is associated with an elevated risk of cutaneous melanoma in Latvian population.
Ozola A, Ruklisa D, Pjanova D
Oncol Lett. 2019; 18(5):5225-5234.
PMID: 31612033
PMC: 6781780.
DOI: 10.3892/ol.2019.10906.
Taking up the reins of power: metabolic functions of p53.
Humpton T, Vousden K
J Mol Cell Biol. 2019; 11(7):610-614.
PMID: 31282931
PMC: 6736434.
DOI: 10.1093/jmcb/mjz065.
mutations and SNPs as prognostic and predictive factors in patients with breast cancer.
Huszno J, Grzybowska E
Oncol Lett. 2018; 16(1):34-40.
PMID: 29928384
PMC: 6006469.
DOI: 10.3892/ol.2018.8627.
Control of metabolism by p53 - Cancer and beyond.
Labuschagne C, Zani F, Vousden K
Biochim Biophys Acta Rev Cancer. 2018; 1870(1):32-42.
PMID: 29883595
PMC: 6102416.
DOI: 10.1016/j.bbcan.2018.06.001.